Detalles de la búsqueda
1.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Hum Vaccin Immunother
; 18(1): 1-14, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726574
2.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090638
3.
Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
Hum Vaccin Immunother
; 14(11): 2624-2631, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29902133
4.
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial.
Atherosclerosis
; 244: 138-46, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26638010
Resultados
1 -
4
de 4
1
Próxima >
>>